• Sectors
    • Tech
    • Healthcare
    • Consumer
    • Energy
    • Mining & Metals
    • Business Services
    • Financials
    • Telecom
    • Industrials
    • Transportation
    • Aerospace & Defense
    • Real Estate
    • Utilities
  • Spotlight Stocks
  • CEO Interview
    • Investor Presentations
  • Newsmakers
  • Investing Strategy
    • Investment Research – Sponsored Reports
    • Analyst Reports
    • Insider Trading
    • Smart Money
  • Funds & ETF’s
  • Markets
    • Commodities
    • Currencies
    • Economy
    • Lending & Interest Rates
  • Business News
    • Trading Ideas
  • Executive Resources
    • Leadership & Strategy
    • Capital
    • Law
  • Investor Education
    • Long Term Investing
    • Personal Finance
    • Stock Trading
    • Options Trading
    • Forex Trading
    • Futures Trading
  • EVENTS
    • Next Super Stock LIVE! – The Online Investor Conference
    • INVESTORS DISCOVERY DAY Livestream
Newswire
  • [ September 15, 2025 ] “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP) CEO Interview
  • [ September 15, 2025 ] Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business CEO Interview
  • [ September 15, 2025 ] NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market CEO Interview
  • [ September 15, 2025 ] Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL! Aerospace & Defense
  • [ September 15, 2025 ] Next Super Stock (NASDAQ: ADN) Hydrogen Fuel Cell Tech: Future of ENERGY $100 Billion Opportunity! Aerospace & Defense
  • [ September 15, 2025 ] (NASDAQ: HOTH) Advances Biotech Portfolio w Multiple Catalysts for 10X Upside Potential CEO Interview
  • [ September 10, 2025 ] Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus Newsmakers
  • [ September 10, 2025 ] Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities Newsmakers
  • [ September 10, 2025 ] Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early Newsmakers
  • [ September 4, 2025 ] Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ]. Newsmakers
Home2021August

Month: August 2021

No Picture
Trading Ideas

How about genuine reform of capital-gains tax rates?

August 4, 2021 admin Comments Off on How about genuine reform of capital-gains tax rates?

…read more […]

No Picture
Trading Ideas

China Goes From Game Clampdown to Sports Boost and Stocks Soar

August 4, 2021 admin Comments Off on China Goes From Game Clampdown to Sports Boost and Stocks Soar

…read more […]

No Picture
Trading Ideas

Ahead of Earnings Release, SoFi Seeming Sufficiently Strong

August 4, 2021 admin Comments Off on Ahead of Earnings Release, SoFi Seeming Sufficiently Strong

…read more […]

No Picture
Trading Ideas

Bonds Are Terrible Deals Right Now. What to Buy Instead.

August 4, 2021 admin Comments Off on Bonds Are Terrible Deals Right Now. What to Buy Instead.

…read more […]

No Picture
Trading Ideas

Virgin Galactic Holdings Pre-Earnings: Will it Soar?

August 4, 2021 admin Comments Off on Virgin Galactic Holdings Pre-Earnings: Will it Soar?

…read more […]

No Picture
Trading Ideas

Sony Group Delivers Profit Growth as SPE and Games Earnings Retreat

August 4, 2021 admin Comments Off on Sony Group Delivers Profit Growth as SPE and Games Earnings Retreat

…read more […]

No Picture
Trading Ideas

Nvidia, Zymergen, General Motors and Roku – 5 Things You Must Know Wednesday

August 4, 2021 admin Comments Off on Nvidia, Zymergen, General Motors and Roku – 5 Things You Must Know Wednesday

…read more […]

No Picture
Trading Ideas

Tencent Boss Loses $14 Billion in Rout, More Than Jack Ma

August 4, 2021 admin Comments Off on Tencent Boss Loses $14 Billion in Rout, More Than Jack Ma

…read more […]

No Picture
Trading Ideas

Alibaba’s First Sales Miss in Two Years Shows Crackdown Toll

August 3, 2021 admin Comments Off on Alibaba’s First Sales Miss in Two Years Shows Crackdown Toll

…read more […]

No Picture
Trading Ideas

Could gold really double in price? This hedge fund says it’s more likely than ever

August 3, 2021 admin Comments Off on Could gold really double in price? This hedge fund says it’s more likely than ever

…read more […]

No Picture
Trading Ideas

Shares of Synthetic Biology Hopeful Zymergen Plunge as CEO Departs

August 3, 2021 admin Comments Off on Shares of Synthetic Biology Hopeful Zymergen Plunge as CEO Departs

…read more […]

No Picture
Trading Ideas

J.P. Morgan Says These 2 Stocks Are Ready to Rip Higher

August 3, 2021 admin Comments Off on J.P. Morgan Says These 2 Stocks Are Ready to Rip Higher

…read more […]

No Picture
Trading Ideas

Tesla Stock Barely Budged Tuesday. Here’s What History Says Happens Next.

August 3, 2021 admin Comments Off on Tesla Stock Barely Budged Tuesday. Here’s What History Says Happens Next.

…read more […]

No Picture
Trading Ideas

Fresh off IPO, ‘biofacturing’ company Zymergen’s stock plunges more than 70% after some really bad news

August 3, 2021 admin Comments Off on Fresh off IPO, ‘biofacturing’ company Zymergen’s stock plunges more than 70% after some really bad news

…read more […]

No Picture
Trading Ideas

Cardlytics shares plunge 23% on Q2 results

August 3, 2021 admin Comments Off on Cardlytics shares plunge 23% on Q2 results

…read more […]

Posts navigation

« 1 … 77 78 79 … 87 »

Featured Stocks

newsmakers

  • Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus
    September 10, 2025 Comments Off on Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus
  • Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities
    September 10, 2025 Comments Off on Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities
  • Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early
    September 10, 2025 Comments Off on Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early
  • Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ].
    September 4, 2025 Comments Off on Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ].
  • Hoth Therapeutics’ (NASDAQ: HOTH) Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards
    September 4, 2025 Comments Off on Hoth Therapeutics’ (NASDAQ: HOTH) Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards
  • No Picture
    Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030
    August 28, 2025 Comments Off on Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030

NEXT SUPER STOCK

  • “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)
    September 15, 2025 Comments Off on “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)
  • Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business
    September 15, 2025 Comments Off on Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business
  • NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market
    September 15, 2025 Comments Off on NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market
  • Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!
    September 15, 2025 Comments Off on Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!

CEO Interview

  • “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)
    September 15, 2025 Comments Off on “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)
  • Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business
    September 15, 2025 Comments Off on Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business
  • NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market
    September 15, 2025 Comments Off on NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market
  • Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!
    September 15, 2025 Comments Off on Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!
Next Super Stock
CEO Interview

“Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)

September 15, 2025 Comments Off on “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)

NEXT SUPER STOCK Worksport (NASDAQ: WKSP) can increase +10X from $3.50 to $50.00 over the next 12 months. Here’s how: revenue $20 mil run rate – growing at +100% over […]

CEO Interview

Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business

September 15, 2025 Comments Off on Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business

NEXT SUPER STOCK Wellgistics (NASDAQ: WGRX) Scaling to $250 Mil+ Revenue next 12 mos. is “Extremely DOABLE” says CEO DO. THE. MATH. This could be worth 4X multiple = $1 […]

CEO Interview

NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market

September 15, 2025 Comments Off on NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market

NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) is an emerging leader in $600 BILLION Pharma distribution market in the US. $WGRX is a young company at INFLECTION POINT for EXPLOSIVE GROWTH […]

Aerospace & Defense

Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!

September 15, 2025 Comments Off on Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!

Next Super Stock Advent Technologies (NASDAQ: ADN) Hydrogen Fuel Cells could be the future of ENERGY for Aviation, Robots, Drones, Ships and more –  $100 BILLION Market Opportunity. $ADN is […]

Aerospace & Defense

Next Super Stock (NASDAQ: ADN) Hydrogen Fuel Cell Tech: Future of ENERGY $100 Billion Opportunity!

September 15, 2025 Comments Off on Next Super Stock (NASDAQ: ADN) Hydrogen Fuel Cell Tech: Future of ENERGY $100 Billion Opportunity!

Next Super Stock Advent Technologies (NASDAQ: ADN) Hydrogen Fuel Cells could be the future of ENERGY for Aviation, Robots, Drones, Ships and more –  $100 BILLION Market Opportunity. $ADN is […]

  • Contact
  • About Us
  • Investor Relations Services
  • Terms of Use/Legal Notice
  • Login
  • Subscriptions
  • Submit Press Release
  • Privacy Policy

Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.